Cargando…

Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial

OBJECTIVE: Although surgical resection is one of the most effective way to treat liver cancer, its efficacy and safety in treatment of centrally located hepatocellular carcinoma (HCC) remains elusive. Therefore, it is very important to find a comprehensive treatment mode, such as radical resection c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Changcheng, Wu, Fan, Wang, Hongwei, Wang, Liming, Liu, Yue, Wu, Anke, Zheng, Linlin, Wang, Yaru, Chen, Bo, Rong, Weiqi, Wu, Jianxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199680/ https://www.ncbi.nlm.nih.gov/pubmed/37215362 http://dx.doi.org/10.2147/JHC.S403287

Ejemplares similares

Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion
por: Wang, Liming, et al.
Publicado: (2017)

Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence
por: Rong, Weiqi, et al.
Publicado: (2020)

The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study
por: Wang, Liming, et al.
Publicado: (2022)

Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion
por: Zhang, Kai, et al.
Publicado: (2021)

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
por: Wang, Liming, et al.
Publicado: (2020)

Noninvasive urinary protein signatures combined clinical information associated with microvascular invasion risk in HCC patients
por: Wang, Yaru, et al.
Publicado: (2023)

Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion
por: Zhang, Kai, et al.
Publicado: (2021)

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis
por: Wang, Liming, et al.
Publicado: (2019)

Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression
por: Feng, Lin, et al.
Publicado: (2021)

A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients
por: Liu, Mei, et al.
Publicado: (2016)

Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial
por: Rong, Weiqi, et al.
Publicado: (2022)

Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways
por: Wang, Liming, et al.
Publicado: (2018)

Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy
por: Wang, Liming, et al.
Publicado: (2015)

Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review
por: Zhang, Kai, et al.
Publicado: (2020)

Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer
por: Fu, Wenyan, et al.
Publicado: (2018)

Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
por: Wu, Jianxiong, et al.
Publicado: (2012)

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy
por: Gao, Lin-Rui, et al.
Publicado: (2022)

Long-Term Outcome of Centrally Located Hepatocellular Carcinomas Treated by Radical Resection Combined With Intraoperative Electron Radiotherapy (IOERT)
por: Wu, Yan-Ling, et al.
Publicado: (2022)

Clinical benefit of neoadjuvant anti‐PD‐1/PD‐L1 utilization among different tumors
por: Li, Zhiyang, et al.
Publicado: (2021)

Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial
por: Bisceglia, Giovanni, et al.
Publicado: (2014)

Enhanced recovery after surgery strategy for cirrhosis patients undergoing hepatectomy: experience in a single research center
por: Zheng, Yiling, et al.
Publicado: (2020)

Prognostic value of the controlling nutritional status (CONUT) score in intrahepatic cholangiocarcinoma patients especially who had long-time alcohol consumption
por: Zheng, Yiling, et al.
Publicado: (2020)

Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma
por: Wo, Yang, et al.
Publicado: (2023)

Clinical Efficacy of Acupuncture on Neoadjuvant Chemotherapy with Capecitabine plus Paclitaxel and Radiotherapy in Progressive Gastric Cancer
por: Miao, Xiaomei, et al.
Publicado: (2022)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis
por: Yang, Jianguo, et al.
Publicado: (2022)

Surgical outcomes of hand-assisted laparoscopic liver resection vs. open liver resection: A retrospective propensity score-matched cohort study
por: Lin, Shengtao, et al.
Publicado: (2019)

Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer
por: Zhou, Juan, et al.
Publicado: (2016)

The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus
por: Bai, Tao, et al.
Publicado: (2016)

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma
por: Zheng, Ruiqi, et al.
Publicado: (2023)

A blind randomized validated convolutional neural network for auto‐segmentation of clinical target volume in rectal cancer patients receiving neoadjuvant radiotherapy
por: Wu, Yijun, et al.
Publicado: (2021)

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study
por: Chen, Zhiju, et al.
Publicado: (2020)

High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study
por: Bi, Chao, et al.
Publicado: (2019)

Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma
por: Shi, Lijun, et al.
Publicado: (2017)

Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer
por: Milecki, Piotr, et al.
Publicado: (2009)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma
por: Huang, Ning, et al.
Publicado: (2023)

Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis
por: Wang, Xia, et al.
Publicado: (2023)

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Xue, Weisong, et al.
Publicado: (2023)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mnf0ruf0bag7n1djdmkviubqoq